2-chloroadenosine has been researched along with Acute Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishizaka, A; Kanazawa, M; Kobayashi, K; Nakamura, H; Sakamaki, F; Sawafuji, M; Sayama, K; Soejima, K; Tasaka, S; Terashima, T; Urano, T; Waki, Y; Yamaguchi, K | 1 |
Fushiki, S; Iwasaki, Y; Matsubara, H; Nagata, K; Takemura, Y; Tando, S; Yokomura, I | 1 |
Dumontet, C; Galmarini, CM; Mackey, JR | 1 |
Blakley, RL; Crom, W; Kearns, C; Mirro, J; Santana, VM; Schell, MJ | 1 |
Belt, J; Brenner, MK; Crom, W; Hurwitz, CA; Krance, R; Mahmoud, H; Ribeirio, R; Roberts, WM; Santana, VM; Schell, MJ | 1 |
1 review(s) available for 2-chloroadenosine and Acute Disease
Article | Year |
---|---|
Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
Topics: 2-Chloroadenosine; 5'-Nucleotidase; Acute Disease; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Gemcitabine; Hematopoietic Cell Growth Factors; Humans; Leukemia, Myeloid; Lymphoproliferative Disorders; Neoplastic Stem Cells; Nucleosides; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Remission Induction; Ribonucleotide Reductases; Vidarabine | 2001 |
2 trial(s) available for 2-chloroadenosine and Acute Disease
Article | Year |
---|---|
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Deoxyadenosines; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Regression Analysis; Remission Induction | 1992 |
Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.
Topics: 2-Chloroadenosine; Acute Disease; Adolescent; Adult; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Child, Preschool; Cladribine; Cytarabine; Daunorubicin; Deoxyadenosines; Etoposide; Humans; Infant; Leukemia, Myeloid, Acute; Remission Induction | 1992 |
2 other study(ies) available for 2-chloroadenosine and Acute Disease
Article | Year |
---|---|
Attenuation by intravenous 2-chloroadenosine of acute lung injury induced by live escherichia coli or latex particles added to endotoxin in the neutropenic state.
Topics: 2-Chloroadenosine; Acute Disease; Animals; Endotoxins; Escherichia coli; Escherichia coli Infections; Guinea Pigs; Injections, Intravenous; Lung Diseases; Microspheres; Neutropenia; Specific Pathogen-Free Organisms; Tumor Necrosis Factor-alpha | 2003 |
Influence of depletion of alveolar macrophages on apoptosis in Candida-induced acute lung injury.
Topics: 2-Chloroadenosine; Acute Disease; Administration, Inhalation; Animals; Apoptosis; Candidiasis; Caspase 3; Caspases; Cytokines; Fungemia; Inflammation Mediators; Lung; Lung Injury; Macrophages, Alveolar; Male; Mice; Mice, Inbred BALB C | 2005 |